Single Patient Expanded Access Treatment Plan For The Investigational Product Narsoplimab

Real-world Outcomes of Aplastic Anemia Patients Treated With Eltrombopag: A Medical Claims Database Study

NCT06991894 ·Status: COMPLETED

Safety and Efficacy of Eltrombopag at Escalated Doses

NCT01880047 ·Status: COMPLETED ·Phase: PHASE2

Nomacopan (rVA576) in Transplant Associated Thrombotic Microangiopathy

NCT04784455 ·Status: TERMINATED ·Phase: PHASE3

Open-Label Study to Evaluate the Safety and Efficacy of Avatrombopag and Remission Rates in Adults With ITP of ≤6 Months

NCT05046327 ·Status: WITHDRAWN ·Phase: PHASE3

Study of Romiplostim for Chemotherapy Induced Thrombocytopenia

NCT02052882 ·Status: COMPLETED ·Phase: PHASE2

Hetrombopag for the Prevention of ADC-Induced Thrombocytopenia in Breast Cancer: An Exploratory, Dual-Cohort, Phase 2 Study

NCT07243418 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Avatrombopag for the Treatment of Thrombocytopenia After Donor Hematopoietic Stem Cell Transplant

NCT04312789 ·Status: WITHDRAWN ·Phase: PHASE2

hATG+CsA vs hATG+CsA+Eltrombopag for SAA

NCT02099747 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Safety and Efficacy of Eltrombopag in Japanese Subjects With Refractory, Moderate or More Severe Aplastic Anemia

NCT02148133 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Romiplostim in Immune Thrombocytopenia (ITP) in the " Real-life " : Result of the French Experience in 72 Adults

NCT01013181 ·Status: COMPLETED

A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic Anemia

NCT03025698 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Study of Herombopag in Tumors-associated Thrombocytopenia

NCT05350956 ·Status: UNKNOWN ·Phase: PHASE2

A Rollover Study to Provide Continued Treatment With Eltrombopag

NCT01957176 ·Status: COMPLETED ·Phase: PHASE4

Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)

NCT04304820 ·Status: RECRUITING ·Phase: PHASE2

Efficacy and Safety of Eltrombopag In Patients With Severe and Very Severe Aplastic Anemia

NCT01703169 ·Status: COMPLETED ·Phase: PHASE2

Effect of Eltrombopag Plus G-CSF on Human CD34+ Cell Mobilization in Multiple Myeloma Patients Undergoing ASCT

NCT01286675 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Phase I Study of Eltrombopag for Promoting Thrombopoiesis After Total Body Irradiation

NCT00903929 ·Status: COMPLETED ·Phase: PHASE1

Thrombosomes® in Bleeding Thrombocytopenic Patients Study

NCT04631211 ·Status: TERMINATED ·Phase: PHASE2

Using ROMIPLOSTINE for Persistent Thrombocytopenia With Transfusion-dependent Patients Who Received Allogeneic Hematopoietic Stem Cell

NCT01980030 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety Study of Eltrombopag Combined With Azacitidine to Treat Myelodysplastic Syndrome (MDS)

NCT01481220 ·Status: COMPLETED ·Phase: PHASE1

Avatrombopag for the Treatment of Thrombocytopenia in Adults With Chronic Liver Disease Undergoing a Procedure

NCT03554759 ·Status: TERMINATED

Individual Patient Compassionate Use of Fedratinib

NCT03723148 ·Status: AVAILABLE

Avatrombopag Usage in NSAA

NCT04728789 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS)

NCT02158936 ·Status: TERMINATED ·Phase: PHASE3

The Prospective Randomized Controlled Study of Eltrombopag on Hematopoietic Reconstruction After Allogeneic HSCT

NCT03902041 ·Status: UNKNOWN